Trials
Search / Trial NCT05659615

Analysis of Breathing Pattern Post COVID-19

Launched by SHIRLEY LIMA CAMPOS · Dec 20, 2022

Trial Information

Current as of January 17, 2025

Unknown status

Keywords

Covid 19 Diagnosis Physiotherapy Breathing Pattern

ClinConnect Summary

This clinical trial, titled "Analysis of Breathing Pattern Post COVID-19," is studying how COVID-19 affects people’s breathing patterns after they have recovered from the virus. Researchers want to understand how different factors, like lung function and muscle strength, relate to breathing changes in individuals who have had COVID-19. To do this, they will use a special device called the Respiratory Diagnostic Assistant (RDA) to measure participants' breathing patterns. The study will follow participants for six months to gather important data that can help improve care for people recovering from COVID-19.

To participate in this study, you must be over 18 years old and have been diagnosed with COVID-19 but are now symptom-free for more than 40 days after your home isolation or hospital discharge. Unfortunately, individuals who are pregnant, unable to complete the assessments, or have had a reinfection with COVID-19 cannot participate. During the study, you can expect to have a clinical interview and a thorough evaluation of your breathing and lung function, all conducted in a friendly and supportive environment at the Federal University of Pernambuco. This research aims to provide better treatment plans for individuals affected by COVID-19, helping to enhance their recovery experience.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Older than 18 years;
  • Diagnosed with COVID-19;
  • After the period of home isolation or hospital discharge;
  • More than 40 days without the presence of symptoms associated with COVID-19;
  • Exclusion Criteria:
  • Participants who are unable to perform the assessment tests or who present contraindications to the assessment of respiratory function;
  • Those patients who prove reinfection by the new Coronavirus;
  • Pregnant patients;
  • Refusal to sign the Free and Informed Consent Form (FICF)

Trial Officials

Shirley L Campos, Phd

Study Director

Universidade Federal de Pernambuco

About Shirley Lima Campos

Shirley Lima Campos is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic interventions, Ms. Campos leads initiatives that prioritize ethical practices and rigorous scientific standards. Her extensive experience in clinical development, combined with a collaborative approach to partnerships, ensures the successful execution of trials that address unmet medical needs. Passionate about enhancing healthcare through evidence-based solutions, she aims to contribute significantly to the field of clinical research.

Locations

Recife, Pe, Brazil

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials